<!DOCTYPE html>
<html>
<head>
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
</head>
<body>
<p><span lang="EN-US">Dear AUC community,</span></p>
<p><span lang="EN-US">We are looking for a person who is at the
beginning of his/her academic career or any later stage of a
scientific career, and has a particular interest in the use and
further development of analytical ultracentrifugation as a
technique for the characterization of macromolecular systems. </span></p>
<p><span lang="EN-US">The situation assumes that this person has
his/her own financial resources, including his/her salary for
the stay at Heinrich Heine University Düsseldorf in Düsseldorf,
Germany. The funding should allow for a stay of at least 2
years.</span></p>
<p><span lang="EN-US">In return, we offer a state-of-the-art working
environment at the Institute of Physical Biology at Heinrich
Heine University Düsseldorf, Germany (<a
href="https://www.ipb.hhu.de/en/" target="_blank"
rel="noreferrer" class="moz-txt-link-freetext">https://www.ipb.hhu.de/en/</a>).
The available laboratories include a level S2 biosafety
laboratory, the possibility to work with prion pathogens under
level S3** conditions and a comprehensive range of equipment for
recombinant protein synthesis and physicochemical
characterization of biological macromolecules. In addition, the
Institute of Structural Biology (IBI-7) at <span>Forschungszentrum</span>
Jülich, which is also headed by Prof. Dr. Willbold, makes a
significant contribution to the available equipment. Cutting
edge equipment for biological NMR spectroscopy together with
the technical expertise on site at Jülich is particularly
noteworthy. Our laboratory already has a <span> ProteomLab</span>
ultracentrifuge in operation equipped with an Aviv fluorescence
detection system and absorption optics. Of special relevance is
a new analytical ultracentrifuge (<span>Optima AUC</span>) with
absorption and interference optics.</span></p>
<p><span lang="EN-US">Most projects in the institute deal with the
pathologic aggregation of proteins associated with human
diseases. Joining our work force would be appreciated but is not
mandatory. For an overview of research activities see our
website <a href="https://www.ipb.hhu.de/en/" target="_blank"
rel="noreferrer" class="moz-txt-link-freetext">https://www.ipb.hhu.de/en/</a>.
</span></p>
<p><span lang="EN-US">Potential sources of funding include the DFG
(Walter Benjamin <span>Programme</span>, Emmy <span>Noether</span>
<span> Programme</span>), EU (Marie <span>Skłodowska</span>-Curie
Actions, ERC grants), Humboldt Research Fellowship, EMBO
(Postdoctoral fellowships, Young Investigator <span>Programme</span>).
</span></p>
<p><span lang="EN-US">Since this message will not reach all possible
candidates, we ask you to forward our message to people who you
think might be interested in our offer.</span></p>
<p><b><span lang="EN-US">Contacts: </span></b></p>
<p><b><span lang="EN-US">Prof. Dr. Dieter Willbold, <a
href="mailto:dieter.willbold@hhu.de" target="_blank"
rel="noreferrer" class="moz-txt-link-freetext">dieter.willbold@hhu.de</a> </span></b></p>
<p><b><span lang="EN-US">Dr. Luitgard Nagel, <a
href="mailto:luitgard.nagel-steger@hhu.de" target="_blank"
rel="noreferrer" class="moz-txt-link-freetext">luitgard.nagel-steger@hhu.de</a></span></b></p>
<p></p>
<pre class="moz-signature" cols="72">--
Dr. Luitgard Nagel
Institut für Physikalische Biologie
Geb.: 26.44.U1
Heinrich-Heine-Universität Düsseldorf
40225 Düsseldorf
</pre>
</body>
</html>